Lasmiditan Ameliorates Serotonergic Itch in Mice: Possible Involvement of 5-HT1F Receptors

Author:

Afrooghe Arya1,Ahmadi Elham1,Babaei Mohammadreza1,Soltani Zahra Ebrahim1,Elahi Mohammad1,Shayan Maryam2,Jafari Razieh Mohammad1,Dehpour Ahmad-Reza1

Affiliation:

1. Tehran University of Medical Sciences

2. Schepens Eye Research Institute, Harvard Medical School

Abstract

Abstract

Purpose Previously, some allergic conditions involving pruritus have been linked to migraine, raising the possibility that migraine and itching may be governed by similar underlying mechanisms. We aimed to investigate the efficacy of lasmiditan, a highly selective agonist of the 5-Hydroxytriptamin 1F receptor (5-HT1FR) and a recently approved medication for the treatment of migraine headaches, in ameliorating serotonergic itching. Methods Eight animals were randomly assigned to each of the study groups: (1) “Sham”: The sham group was given intradermal injections of normal saline (2) “Ctrl”: The control group was injected with intradermal doses of 5-HT, which was used to induce itching. (3) “Las 0.3”, “Las 1”, and “Las 3” groups: injected with 5-HT as well as intraperitoneal lasmiditan at different dose levels (0.3, 1, and 3 mg/kg, respectively). scratching behavior was recorded for 60 minutes, and the skin tissue of three mice was sampled at the end of the behavioral experiment to assess the levels of TLR-4, IL-31, 5-HT1FR, CGRP & TRPV4. Results In the present study, we found that Lasmiditan when administered at 1mg/kg effectively reduced serotonin-induced itching compared to the “Ctrl” group (P < 0.0001). Following the administration of Lasmiditan (1mg/kg), the expression levels of the 5-HT2A receptor significantly increased (P < 0.01). Further, the levels of TLR-4, IL-31, CGRP & TRPV4 were substantially reduced upon the administration of Lasmiditan (1mg/kg). Conclusions We found that Lasmiditan is effective in reducing serotonergic itch in mice through its interaction with the 5-HT1F receptor in the skin tissue of mice.

Publisher

Springer Science and Business Media LLC

Reference28 articles.

1. Disease mechanisms in neuropathic itch;Binder A;Nat Clin Pract Neurol,2008

2. Therapeutic potential of bromhexine for acute itch in mice: Involvement of TMPRSS2 and kynurenine pathway;Afrooghe A;Int Immunopharmacol,2023

3. Epidemiology of Itch;Weisshaar E;Curr Probl Dermatol,2016

4. Physiology and Pathophysiology of Itch;Cevikbas F;Physiol Rev,2020

5. Itch: A Global Problem?;Weisshaar E;Front Med (Lausanne),2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3